BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:In the high-stakes world of radiopharmaceuticals\, the industr
 y is just beginning to realize the full potential of this targeted therap
 y modality. A surge of capital flowing into the field is signalling not o
 nly robust investment\, but a shared urgency to strengthen supply pipelin
 es and scale clinical manufacturing capacity.\n\nAlongside this growth\, 
 however\, the challenge of consistently delivering safe\, scalable\, and 
 timely radiopharmaceuticals to patients remains.\n\nThe 3rd Targeted Radi
 opharmaceuticals (TRP) Supply Chain and Manufacturing Summit returns to B
 oston this September to help you strengthen infrastructure\, streamline w
 orkflows\, and future-proof roles in a rapidly evolving and expanding rad
 iopharmaceutical landscape.\n\nExplore how to optimize production capabil
 ities and build a resilient\, efficient supply chain by delving into crit
 ical topics such as strategic isotope selection\, manufacturing scale-up\
 , supplier quality control\, regulatory transparency\, and last-mile supp
 ly networks.\n\nAs the only industry-dedicated forum uniting 70+ of the l
 eading C-suite and senior decision-makers in the radiopharmaceutical CMC\
 , regulatory\, QC\, and supply chain fields\, gain exclusive technical an
 d logistical insights from the likes of from AstraZeneca\, Novartis\, Cla
 rity Pharmaceuticals\, Ratio Therapeutics\, ImaginAB\, and more.\n\nURLs:
 Tickets: https://go.evvnt.com/3119139-2?pid=185Brochure: https://go.evvnt
 .com/3119139-3?pid=185\n\nTime: 8:00 AM - 4:00 PM\n\nPrices:Drug Develope
 r Full Package (Conference + Pre-Conference Workshop Day): USD 4197.00\,D
 rug Developer Conference Only: USD 2999.00\,Solution Provider Full Packag
 e (Conference + Pre-Conference Workshop Day): USD 5097.00\,Solution Provi
 der Conference Only: USD 3699.00\n\nSpeakers: Angel Colina\, Director - C
 yclotron Engineering and Operations\, Columbia University Irving Medical 
 Center\, Barbara Lani\, Vice President - Quality Affairs\, RadioPharm The
 ranostics\, Brett Miller\, Senior Director - Global Supply Chain\, Telix 
 Pharmaceuticals\, Christian Schmidt\, Quality Assurance Manager\, Ratio T
 herapeutics\, Christopher Adams\, Chief Executive Officer\, Andarix Pharm
 aceuticals\, Dawn Spiller\, Senior Director and Group Manager\, AstraZene
 ca\, Geoffrey Johnson\, Associate Director- Comprehensive Cancer Center a
 nd Nuclear Medicine\, Mayo Clinic\, Hayley Jackman\, Director - CMC Regul
 atory Affairs\, AstraZeneca\, Ira Goldman\, Nuclear Medicine Industry and
  Legislative Affairs\, Bartlett Hill Enterprises\, Jarrod Longcor\, Chief
  Operating Officer\, Cellectar Biosciences Inc.\, Kathleen Brady\, Associ
 ate Director - Quality Assurance\, Imaginab\, Kawa Chiu\, Chief Technical
  Officer\, Abdera Therapeutics\, Lauren Creeden\, Head of Clinical\, Chem
 istry Manufacturing and Controls Execution\, Clarity Pharmaceuticals\, Mu
 nir Ghesani\, Chief Medical Officer\, United Theranostics\, Sergio Cerdas
 \, Global Head of Radioligand Therapies and Technical Operations\, Novart
 is AG\, Shaemus Gleason\, Executive Vice President\, Clarity Pharmaceutic
 als\, Shankar Vallabhajosula\, VP Radiopharmaceutical Sciences\, Converge
 nt Therapeutics\, Inc\n
DTEND:20250925T160000
DTSTAMP:20260512T232258Z
DTSTART:20250923T080000
LOCATION:Revere Hotel Boston Common\, 200\, Stuart Street\, Boston\, Massa
 chusetts\, 02116\,
SEQUENCE:0
SUMMARY:In the high-stakes world of radiopharmaceuticals\, the industry is
  just beginning to realize the full potential of this targeted therapy mo
 dality. A...
UID:3588979f-c2c8-419e-8dc1-d326c58b34c1
END:VEVENT
END:VCALENDAR